v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (446,315) $ (1,363,964)
Reconciling items:    
Depreciation 167,170 184,391
Amortization 146,588 180,394
Amortization of non-recoupable ticketing contract advances 49,214 38,833
Deferred income tax expense (benefit) 4,365 (22,615)
Amortization of debt issuance costs and discounts 27,916 24,201
Non-cash compensation expense 80,165 106,965
Unrealized changes in fair value of contingent consideration (6,998) (25,745)
Equity in losses of nonconsolidated affiliates, net of distributions 6,396 8,266
Provision for uncollectible accounts receivable (14,006) 48,413
Gain (Loss) on Sale of Investments 83,580 2,479
Other, net 2,015 (12,681)
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Decrease (increase) in accounts receivable (690,105) 406,202
Decrease (increase) in prepaid expenses and other assets (92,635) 1,793
Increase (decrease) in accounts payable, accrued expenses and other liabilities 1,323,448 (1,213,409)
Increase in deferred revenue 551,059 684,532
Net cash provided by (used in) operating activities 1,024,697 (956,903)
CASH FLOWS FROM INVESTING ACTIVITIES    
Advances of notes receivable (24,476) (12,232)
Collections of notes receivable 16,500 13,838
Investments made in nonconsolidated affiliates (55,246) (9,728)
Purchases of property, plant and equipment (103,914) (187,036)
Cash paid for acquisitions, net of cash acquired (19,594) (37,283)
Proceeds from Sale of Long-term Investments 80,593 3,753
Other, net (5,622) 4,156
Net cash used in investing activities (111,759) (224,532)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 904,164 1,608,462
Payments on long-term debt (93,168) (24,202)
Contributions from noncontrolling interests 15,985 2,568
Distributions to noncontrolling interests (25,632) (31,473)
Purchases and sales of noncontrolling interests, net (3,273) (106,971)
Proceeds from sale of common stock, net of issuance costs 449,415 0
Proceeds from exercise of stock options 30,322 18,092
Taxes paid for net share settlement of equity awards (42,731) (42,818)
Payments for deferred and contingent consideration (12,845) (62,035)
Other, net 84 13
Net cash provided by financing activities 1,222,321 1,361,636
Effect of exchange rate changes on cash, cash equivalents and restricted cash (48,501) (20,952)
Net increase in cash, cash equivalents, and restricted cash 2,086,758 159,249
Cash, cash equivalents, and restricted cash at beginning of period 2,546,439 2,474,242
Cash, cash equivalents, and restricted cash at end of period $ 4,633,197 $ 2,633,491

Source